Plant ID: NPO18443
Plant Latin Name: Aristolochia manshuriensis
Taxonomy Genus: Aristolochia
Taxonomy Family: Aristolochiaceae
NCBI TaxonomyDB:
158555
Plant-of-the-World-Online:
n.a.
China
GPBAR1; | |
PTPN1; PTPN2; CDC25B; | |
PLA2G1B; AKR1B10; POLB; | |
CDK2; CDK1; CDK4; AURKB; AURKA; | |
CA1; CA12; CA9; CA2; CA5B; CA3; CA14; CA7; CA5A; CA4; CA6; | |
NR1H4; | |
ESR2; | |
SLCO1B3; SLCO1B1; | |
SMN1;SMN2; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | PLA2G1B | Phospholipase A2 group 1B | P04054 | CHEMBL4426 |
Enzyme_unclassified | AKR1B10 | Aldo-keto reductase family 1 member B10 | O60218 | CHEMBL5983 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA5B | Carbonic anhydrase VB | Q9Y2D0 | CHEMBL3969 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Nuclear hormone receptor subfamily 3 group A | ESR2 | Estrogen receptor beta | Q92731 | CHEMBL242 |
Protein Kinase | CDK2 | Cyclin-dependent kinase 2 | P24941 | CHEMBL301 |
Protein Kinase | CDK1 | Cyclin-dependent kinase 1 | P06493 | CHEMBL308 |
Protein Kinase | CDK4 | Cyclin-dependent kinase 4 | P11802 | CHEMBL331 |
Protein Kinase | AURKB | Serine/threonine-protein kinase Aurora-B | Q96GD4 | CHEMBL2185 |
Protein Kinase | AURKA | Serine/threonine-protein kinase Aurora-A | O14965 | CHEMBL4722 |
Protein Phosphatase | PTPN1 | Protein-tyrosine phosphatase 1B | P18031 | CHEMBL335 |
Protein Phosphatase | PTPN2 | T-cell protein-tyrosine phosphatase | P17706 | CHEMBL3807 |
Protein Phosphatase | CDC25B | Dual specificity phosphatase Cdc25B | P30305 | CHEMBL4804 |
SLC superfamily of solute carriers | SLCO1B3 | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | CHEMBL1743121 |
SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
Small molecule receptor (family A GPCR) | GPBAR1 | G-protein coupled bile acid receptor 1 | Q8TDU6 | CHEMBL5409 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 7.296E-11 | 1.589E-07 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR2, NR1H4, PTPN1 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 2.130E-29 | 4.637E-25 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0050896; response to stimulus | GO:0046626; regulation of insulin receptor signaling pathway | 9.540E-07 | 1.039E-03 | CDK4, NR1H4, PTPN1, PTPN2 |
CC | GO:0043226; organelle | GO:0005876; spindle microtubule | 1.313E-06 | 1.299E-03 | AURKA, AURKB, CDK1, POLB |
BP | GO:0009987; cellular process | GO:0090068; positive regulation of cell cycle process | 3.440E-06 | 3.121E-03 | AURKA, AURKB, CDC25B, CDK1, CDK2, CDK4 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 6.989E-06 | 5.073E-03 | CA2, CA7 |
BP | GO:0009987; cellular process | GO:0038183; bile acid signaling pathway | 6.989E-06 | 5.073E-03 | GPBAR1, NR1H4 |
MF | GO:0060089; molecular transducer activity | GO:0038181; bile acid receptor activity | 6.989E-06 | 5.073E-03 | GPBAR1, NR1H4 |
BP | GO:0009987; cellular process | GO:1902751; positive regulation of cell cycle G2/M phase transition | 7.598E-06 | 5.267E-03 | CDC25B, CDK1, CDK4 |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 9.195E-06 | 6.067E-03 | CA2, CA4, CA9, SLCO1B1, SLCO1B3 |
BP | GO:0009987; cellular process | GO:0010389; regulation of G2/M transition of mitotic cell cycle | 1.245E-05 | 7.972E-03 | AURKA, AURKB, CDK1, CDK2, CDK4 |
BP | GO:0051179; localization | GO:0015721; bile acid and bile salt transport | 1.334E-05 | 8.218E-03 | NR1H4, SLCO1B1, SLCO1B3 |
BP | GO:0009987; cellular process | GO:1902202; regulation of hepatocyte growth factor receptor signaling pathway | 1.396E-05 | 8.218E-03 | PTPN1, PTPN2 |
MF | GO:0005488; binding | GO:0030332; cyclin binding | 1.476E-05 | 8.456E-03 | CDK1, CDK2, CDK4 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.166E-22 | 1.269E-18 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 3.749E-21 | 1.633E-17 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0004693; cyclin-dependent protein serine/threonine kinase activity | 2.140E-05 | 1.165E-02 | CDK1, CDK2, CDK4 |
CC | GO:0032991; macromolecular complex | GO:0032133; chromosome passenger complex | 2.325E-05 | 1.192E-02 | AURKA, AURKB |
CC | GO:0044464; cell part | GO:0000307; cyclin-dependent protein kinase holoenzyme complex | 3.463E-05 | 1.548E-02 | CDK1, CDK2, CDK4 |
CC | GO:0043226; organelle | GO:0015030; Cajal body | 7.097E-05 | 2.711E-02 | CDK2, SMN1, SMN2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.314E-28 | 7.887E-27 | CA12, CA1, CA3, CA5B, CA2, CA5A, CA4, CA7, CA6, CA9, CA14 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 6.498E-08 | 1.949E-06 | SLCO1B1, CA2, SLCO1B3, NR1H4, CYP3A4 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04110 | Cell cycle | 3.405E-05 | 6.809E-04 | CDK4, CDK2, CDK1, CDC25B |
09160 Human Diseases | 09161 Cancers | hsa05203 | Viral carcinogenesis | 2.384E-04 | 2.860E-03 | POLB, CDK4, CDK2, CDK1 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04115 | p53 signaling pathway | 1.493E-04 | 2.239E-03 | CDK4, CDK2, CDK1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04914 | Progesterone-mediated oocyte maturation | 4.208E-04 | 4.208E-03 | CDK2, CDK1, CDC25B |
09140 Cellular Processes | 09143 Cell growth and death | hsa04114 | Oocyte meiosis | 8.163E-04 | 5.741E-03 | CDK2, CDK1, AURKA |
09150 Organismal Systems | 09155 Excretory system | hsa04964 | Proximal tubule bicarbonate reclamation | 5.396E-04 | 4.625E-03 | CA2, CA4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 8.611E-04 | 5.741E-03 | PLA2G1B, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05222 | Small cell lung cancer | 7.352E-03 | 4.411E-02 | CDK4, CDK2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Thymoma | C37, D15.0 | CDK2; |
C00-D49: Neoplasms | Breast cancer | C50 | CDK1; |
C00-D49: Neoplasms | Cancer | C00-C96 | CDK2; CDK1; CDC25B; |
C00-D49: Neoplasms | Acute lymphoblastic leukemia | C91.0 | CDK2; |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
C00-D49: Neoplasms | Non-small cell lung cancer | C33-C34 | CDK2; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2; |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |
NA: NA | Edema | NA | CA2; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | CDK1; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CDK2; |